title: Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages.
abstract: In inflammation, bacterial products and proinflammatory cytokines induce the formation of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS), and compounds that inhibit NO production have anti-inflammatory effects. In the present study, we systematically investigated the effects of 36 naturally occurring flavonoids and related compounds on NO production in macrophages exposed to an inflammatory stimulus (lipopolysaccharide, LPS), and evaluated the mechanisms of action of the effective compounds. Flavone, the isoflavones daidzein and genistein, the flavonols isorhamnetin, kaempferol and quercetin, the flavanone naringenin, and the anthocyanin pelargonidin inhibited iNOS protein and mRNA expression and also NO production in a dose-dependent manner. All eight active compounds inhibited the activation of nuclear factor-kappaB (NF-kappaB), which is a significant transcription factor for iNOS. Genistein, kaempferol, quercetin, and daidzein also inhibited the activation of the signal transducer and activator of transcription 1 (STAT-1), another important transcription factor for iNOS. The present study characterises the effects and mechanisms of naturally occurring phenolic compounds on iNOS expression and NO production in activated macrophages. The results partially explain the pharmacological efficacy of flavonoids as anti-inflammatory compounds.
authors.affiliation: The Immunopharmacology Research Group, University of Tampere, Medical School and Tampere University Hospital, Research Unit, Tampere 33014, Finland.
authors.forename: Mari
authors.initials: M
authors.lastname: Hämäläinen
authors.forename: Riina
authors.initials: R
authors.lastname: Nieminen
authors.forename: Pia
authors.initials: P
authors.lastname: Vuorela
authors.forename: Marina
authors.initials: M
authors.lastname: Heinonen
authors.forename: Eeva
authors.initials: E
authors.lastname: Moilanen
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D044950:Flavanones / Q000494:pharmacology; D047309:Flavones / Q000494:pharmacology; D044948:Flavonols / Q000494:pharmacology; D019833:Genistein / Q000494:pharmacology; D007529:Isoflavones / Q000494:pharmacology; D044949:Kaempferols / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism*; D011794:Quercetin / Q000494:pharmacology / Q000031:analogs & derivatives; D050794:STAT1 Transcription Factor / Q000378:metabolism*
chemical_list: D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D044950:Flavanones; D047309:Flavones; D044948:Flavonols; D007529:Isoflavones; D044949:Kaempferols; D007659:Ketones; D016328:NF-kappa B; D050794:STAT1 Transcription Factor; C494080:Stat1 protein, mouse; C047368:3-methylquercetin; D009569:Nitric Oxide; C050509:9-heptadecanone; C004742:daidzein; C006552:kaempferol; D011794:Quercetin; D019833:Genistein; D052247:Nitric Oxide Synthase Type II; C005273:naringenin